Skip to main content
. 2013 Aug 7;6:657–664. doi: 10.2147/IJGM.S45880

Table 2.

Change in average daily frequency of moderate or severe hot flashes from baseline after 12 weeks of treatment relative to placebo

Doses BREEZE 1 BREEZE 2
1,200 mg −0.56 ± 0.42
(P = 0.1830)
−1.56 ± 0.51
(P = 0.0024)
1,800 mg −1.53 ± 0.41
(P = 0.1975)
−1.12 ± 0.51
(P = 0.0281)